Saint Luke's Marion Bloch Neuroscience Institute Announces 2014 Symposium

Share Article

Conference to focus on diagnosis and treatment of a broad range of neurological disorders.

Saint Luke’s Marion Bloch Neuroscience Institute (SLMBNI), one of the region’s pre-eminent neurological facilities, in conjunction with the University of Missouri – Kansas City (UMKC) School of Medicine and Saint Luke’s Hospital of Kansas City will present the Saint Luke’s Marion Bloch Neuroscience Institute 2014 Symposium on Sept. 19, 2014 at Bartle Hall – Kansas City Convention Center.

The symposium is for primary care physicians, family physicians, neurosurgeons, neurologists, neurointensivists, psychiatrists, nurses, case managers and social workers, EMS providers and other health care professionals. The program will focus on a multidisciplinary approach to patients with neurologic disorders and review current treatment paradigms.

Lectures and break-out sessions will focus on movement disorders, stroke, epilepsy, neurointerventional care, brain tumor surgery, relationship of hearing loss and dementia, traumatic head injury and spinal cord injury, neurorehabilitation, dizziness, neuroradiology and healthy brain aging. Specialized breakout sessions will be provided for physicians, nurses, and EMS providers. Speakers will include leading neurologists, neurosurgeons, and neuropsychiatrists speaking about new approaches for diagnosis and treatment of a wide array of neurological illnesses and disorders.

“The topics and treatments to be discussed at the 2014 Symposium offer some of the latest, most ground-breaking advances and treatment techniques in our field,” said Darren Lovick, M.D., Saint Luke’s Marion Bloch Neuroscience Institute surgical director. “We are incredibly excited to be able to offer this learning opportunity to physicians and nurses locally and regionally.”

The symposium will be held Sept. 19, 2014, at Bartle Hall – Kansas City Convention Center, 301 West 13th Street in Kansas City, between 7:30 a.m. and 5:15 p.m. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the UMKC School of Medicine and Saint Luke’s Hospital of Kansas City. The UMKC School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The UMKC School of Medicine designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credits™. Saint Luke’s Health System is an approved provider of continuing nursing education by the Missouri Nurses Association and this event represents 8.0 contact hours, including up to 5.5 hours of stroke and 3.0 hours of trauma. For EMS providers, 8.0 hours of MO EMS CE is provided by LifeFlight Eagle. The event has been approved for up to 8.0 credits by the American Academy of Family Physicians and has been approved by the American College of Emergency Physicians for a maximum of 8.0 hours of ACEP Category I credit.

Health care professionals interested in registering online for the SLMBNI 2014 Symposium can do so by visiting https://cmetracker.net/UMKC/Catalog or by contacting UMKC Continuing Medical Education office at 816-235-6808 or cmeoffice(at)umkc(dot)edu.

About Saint Luke’s Marion Bloch Neuroscience Institute
Saint Luke’s Marion Bloch Neuroscience Institute (SLMBNI), a member of Saint Luke’s Health System, is a global leader in utilizing both drug and mechanical interventions to block and reverse the permanent and debilitating effects of ischemic strokes. Its legacy of innovation began in 1993 when doctors performed one of the world’s first intra-arterial stroke reversal procedures. Since then, Saint Luke’s specialists have continued to pioneer new stroke treatments and reverse stroke’s debilitating effects for thousands of patients, and is one of the world’s most experienced and prolific leaders in the use of Tissue Plasminogen Activator (t-PA) clot-busting medication for treatment of ischemic stroke. SLMBNI, headquartered in Kansas City, Mo., brings together a team of the country’s most accomplished neuroscience experts to provide a comprehensive treatment center for the most complex neurological issues, such as stroke, epilepsy, brain tumors, facial pain, Parkinson’s disease, Alzheimer’s, headaches, aneurysms, and the latest in minimally invasive spinal surgical techniques. SLMBNI’s advancements in neurology have made it a national leader in neurological treatment and care.

About Saint Luke’s Health System
Saint Luke’s Health System consists of 10 area hospitals and several primary and specialty care practices, and provides a range of inpatient, outpatient, and home care services. Founded as a faith-based, not-for-profit organization, our mission includes a commitment to the highest levels of excellence in health care and the advancement of medical research and education. The health system is an aligned organization in which the physicians and hospitals assume responsibility for enhancing the physical, mental, and spiritual health of people in the Kansas City metropolitan area and the surrounding region. Find us on Facebook and follow us on Twitter.

About University of Missouri – Kansas City School of Medicine
The University of Missouri – Kansas City School of Medicine was founded in 1971 as an innovative combined degree program. From its baccalaureate/MD curriculum to a docent system that emphasizes small group learning, the school has remained a trendsetter in medical education and research. For more information about the UMKC School of Medicine, visit med.umkc.edu. You can also find them on Facebook and Twitter.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michelle Manuel